1887

Abstract

SUMMARY

Simian virus 5 (SV5) isolates derived after co-cultivation of human bone marrow aspirates of multiple sclerosis (MS) patients were shown by immunoprecipitation, cross-neutralization and haemagglutination inhibition techniques to be similar antigenically but not identical to the prototype strain. Analyses of human sera (MS and control) showed that about 20% contained neutralizing antibodies to SV5 and immunoprecipitated the specific SV5 HN polypeptide. A competition assay using a specific SV5 monoclonal antibody confirmed that a human serum containing such neutralizing activity also blocked a specific SV5 epitope whereas another human serum with demonstrable antibodies to the related human parainfluenza virus type 2 did not block this epitope. These tests therefore suggested that SV5 can infect humans. However, there was no indication, on the basis of these tests, of any aetiological relationship of the SV5 infection to the induction of MS.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-65-8-1295
1984-08-01
2024-12-03
Loading full text...

Full text loading...

/deliver/fulltext/jgv/65/8/JV0650081295.html?itemId=/content/journal/jgv/10.1099/0022-1317-65-8-1295&mimeType=html&fmt=ahah

References

  1. Aulisio C. G., Wono D. C., Morris J. A. 1964; Neutralizing antibodies against simian viruses SV5 and SV20 in human sera. Proceedings of the Society for Experimental Biology and Medicine 117:6–11
    [Google Scholar]
  2. Baumgartner W. K., Metzler A. E., Krakowka S., Koestner A. 1981; In vitro identification and characterization of a virus isolated from a dog with neurological dysfunction. Infection and Immunity 31:1177–1183
    [Google Scholar]
  3. Cornwell H. I. C., McCandish I. A. P., Thompson H., Laird H. M., Wright N. G. 1976; Isolation of para-influenza virus SV5 from dogs with respiratory disease. Veterinary Record 98:301–303
    [Google Scholar]
  4. Evermann J. F., Lincoln J. D., McKlernan A. J. 1980; Isolation of a paramyxovirus from the cerebrospinal fluid of a dog with posterior paresis. Journal of the American Veterinary Medical Association 111:1132–134
    [Google Scholar]
  5. Goswami K. K. A., Russell W. C. 1982; A comparison of paramyxoviruses by immunoprecipitation. Journal of General Virology 60:177–183
    [Google Scholar]
  6. Goswami K. K. A., Russell W. C. 1983; Monoclonal antibodies against human paramyxovirus type 3 and against SV5 virus: preparation and preliminary characterization. Journal of General Virology 64:1663–1672
    [Google Scholar]
  7. Hsiung G. D. 1972; Parainfluenza-5 virus. Infection of man and animal. Progress in Medical Virology 14:241–274
    [Google Scholar]
  8. Hsiung G. D., Isacson P., McCollum R. W. 1962; Studies of amyxovirus isolated from human blood. I. Isolation and properties. Journal of Immunology 88:284–290
    [Google Scholar]
  9. Hsiung G. D., Isacson P., Tucker G. 1963; Studies of parainfluenza viruses. II. Serologic interrelationships in humans. Yale Journal of Biology and Medicine 35:534–544
    [Google Scholar]
  10. Hull R. N., Minner J. R., Smith J. W. 1956; New viral agents recovered from tissue cultures of monkey kidney cells. I. Origin and properties of cytopathogenic agents SV1, SV2, SV4, SV5, SV6, SV11, SV12 and SV15. American Journal of Hygiene 63:204–215
    [Google Scholar]
  11. Itoh H., Morimoto Y., Doi Y., Sanpe T. 1968; Studies on simian viruses. Some properties of SV41 grown in Vero cell cultures and search for serum neutralizing antibodies in humans and various animals. Virus 18:495–503
    [Google Scholar]
  12. Mautner V., Willcox H. N. A. 1974; Adenovirus antigens: a model system in mice for subunit vaccination. Journal of General Virology 25:325–336
    [Google Scholar]
  13. Mitchell D. N., Porterfield J. S., Micheletti R., Lange L. S., Goswami K. K. A., Taylor P., Jacobs J. P., Hockley D. J., Salsbury A. J. 1978; Isolation of an infectious agent from bone-marrows of patients with multiple sclerosis. Lancet ii:387–391
    [Google Scholar]
  14. Mitchell D. N., Goswami K. K. A., Taylor P., Salsbury A. J., Porterfield J. S., Micheletti R., Lange L. S., Jacobs J. P., Hockley D. J., Taylor-Robinson D. A. 1979; Failure to isolate a transmissible agent from the bone-marrow of patients with multiple sclerosis. Lancet ii:415–416
    [Google Scholar]
  15. Robbins S. J., Wrzos H., Kline A. L., Tenser R. B., Rapp F. 1981; Rescue of a cytopathic paramyxovirus from peripheral blood leukocytes in subacute sclerosing panencephalitis. Journal of Infectious Diseases 143:396–403
    [Google Scholar]
  16. Russell W. C., Newman C., Williamson D. H. 1975; A simple cytochemical technique for demonstration of DNA in cells infected with mycoplasmas and viruses. Nature, London 253:461–462
    [Google Scholar]
  17. Schultz E. W., Habel K. 1959; S.A. virus. A new member of the myxovirus group. Journal of Immunology 82:274–78
    [Google Scholar]
  18. Suissa M. 1983; Spectrophotometric quantitation of silver grains eluted from autoradiograms. Analytical Biochemistry 133:511–514
    [Google Scholar]
  19. Zakstelskava L. Ya., Zhdanov V. M., Yakhno M. A., Gushchin B. V., Klimenko S. M., Demidova S. A., Konovalova N. G., Gushchina E. A. 1976; Persistent SV5 virus infection in continuous cell cultures. Acta virologica 20:506–511
    [Google Scholar]
/content/journal/jgv/10.1099/0022-1317-65-8-1295
Loading
/content/journal/jgv/10.1099/0022-1317-65-8-1295
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error